BOSTON, April 8, 2015 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced three new academic programs at the PAREXEL Academy. The offerings span the globe and are designed to prepare students for careers in the biopharmaceutical industry:
Bachelor of Science Degree in Clinical Research – Offered in partnership with the Medical School Berlin, in Berlin, Germany, the degree program features courses specific to clinical research. Courses range from ethics in health and medicine to conducting clinical trials. Several courses are taught by PAREXEL experts.
Postgraduate Certificate in Clinical Trial Management – In cooperation with Salem State University in Salem, Massachusetts, the postgraduate certificate program features a broad-based curriculum in various components of the full life cycle of drug development.
Joint Program for Clinical Research and Clinical Trial Management – In collaboration with Kyoto Pharmaceutical University in Kyoto, Japan, the joint program provides fifth grade undergraduate students an introductory, seven-week course in clinical research and clinical trial management.
“PAREXEL is committed to developing the biopharmaceutical industry’s next-generation global workforce,” said Heidrun Bruchmann, Ph.D., Senior Director, PAREXEL Academy. “Through the PAREXEL Academy, we tailor educational and degree programs with our partners to equip the future health sciences workforce with a holistic and cross-functional foundation in clinical research and clinical trial management.”
For more than a decade, the PAREXEL Academy has designed and implemented a wide range of learning programs tailored to enable clinical research management practices for learners inside and outside of PAREXEL. The PAREXEL Academy has locations in the United States, Europe, and Asia. Since inception, approximately 1,000 students have graduated from the Academy’s programs, including its undergraduate Bachelor of Science program.
Mary L. Churchill, Ph.D. Associate Provost, Innovation and Partnerships, Salem State University, commented that “Salem State is committed to providing students with programs that are both foundational and workforce-aligned. Through our partnership with the PAREXEL Academy, we create programs to give students the specific tools needed to succeed post-graduation in biopharmaceutical research.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.